Please use this identifier to cite or link to this item: https://doi.org/10.1167/iovs.17-22694
DC FieldValue
dc.titleBevacizumab Promotes T-Cell-Mediated Collagen Deposition in the Mouse Model of Conjunctival Scarring
dc.contributor.authorSeet L.-F.
dc.contributor.authorToh L.Z.
dc.contributor.authorChu S.
dc.contributor.authorFinger S.N.
dc.contributor.authorGinhoux F.
dc.contributor.authorHong W.
dc.contributor.authorWong T.T.
dc.date.accessioned2019-03-12T08:10:22Z
dc.date.available2019-03-12T08:10:22Z
dc.date.issued2018
dc.identifier.citationSeet L.-F., Toh L.Z., Chu S., Finger S.N., Ginhoux F., Hong W., Wong T.T. (2018). Bevacizumab Promotes T-Cell-Mediated Collagen Deposition in the Mouse Model of Conjunctival Scarring. Investigative ophthalmology & visual science 59 (3) : 1682-1692. ScholarBank@NUS Repository. https://doi.org/10.1167/iovs.17-22694
dc.identifier.issn15525783
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/152204
dc.description.abstractPurpose: We determine the effects of bevacizumab on collagen production in a mouse model of conjunctival scarring.Methods: Experimental surgery was performed as described for the mouse model of conjunctival scarring, and bevacizumab was introduced by conjunctival injection. The capacity of bevacizumab to recognize conjunctival VEGF-A was determined by ELISA. Col1a1 was measured by real-time PCR and immunoblotting. T cells and collagen were visualized by immunofluorescence and picrosirius red staining of bleb cryosections. Conjunctival CD4+ or CD8a+ T cells were counted by flow cytometry. Mouse splenic T cells were cultured with bevacizumab/IgG and their numbers, cell cycle, and collagen production were measured using a cell counter, flow cytometry, and sircol soluble collagen assay, respectively. Reconstitution experiments in severe combined immunodeficiency (SCID) mice were performed by injection of freshly isolated T cells on day 2 postoperatively.Results: Bevacizumab recognized approximately 20% of endogenous murine VEGF-A. Injection of bevacizumab raised Col1a1 expression in the blebs at mRNA and protein levels. Bevacizumab did not induce collagen in conjunctival fibroblasts, but increased CD4+ and CD8a+ cell numbers as well as collagen production by these cells. Collagen appeared to accumulate in the vicinity of T cells in the bevacizumab-treated blebs. While SCID blebs did not show elevated collagen levels, reconstitution with CD4+ or CD8a+ cells resulted in increased Col1a1 expression at mRNA and protein levels.Conclusions: Bevacizumab increased collagen production in the mouse model of conjunctival scarring. This collagen induction was mediated by T cells that were also stimulated by bevacizumab to increase in numbers.
dc.sourceScopus
dc.subjectbevacizumab
dc.subjectcollagen
dc.subjectconjunctiva
dc.subjectT cells
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.contributor.departmentDEPT OF PHYSIOLOGY
dc.contributor.departmentDEPT OF MICROBIOLOGY & IMMUNOLOGY
dc.contributor.departmentDEPT OF BIOCHEMISTRY
dc.description.doi10.1167/iovs.17-22694
dc.description.sourcetitleInvestigative ophthalmology & visual science
dc.description.volume59
dc.description.issue3
dc.description.page1682-1692
dc.published.statepublished
dc.grant.idNMRC/CG/015/2013
dc.grant.fundingagencySingapore National Research Foundation
dc.grant.fundingagencySingapore Ministry of Health抯 National Medical Research Council
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
59-3-1682.pdf1.56 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.